Proceedings of 48th Annual General Meeting of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences held its 48th AGM on 5th September 2025 at 4:00 PM via video conferencing, attended by 27 members, and concluded at 4:45 PM. All six directors, the CFO, and the Company Secretary were present, along with the statutory and secretarial auditors. The Chairman, Mr. Laxmikant Kabra, shared the company's vision and growth opportunities and addressed shareholder questions. Eight resolutions were transacted, including adoption of FY25 audited financial statements, re-appointment of Mr. Laxmikant Kabra (retiring by rotation), appointment of a Secretarial Auditor for five years, approval of material related party transactions, increase in authorized share capital, appointment of Mr. Sumukh Vartak as Whole-Time Director, and re-appointment of two Independent Directors (Ms. Kajal Kothari and Mr. Rajkumar Baheti). The document does not disclose voting results for the resolutions.
The authorized share capital increase and material related party transaction approvals are the most material items, potentially enabling future fundraising or corporate restructuring. New and renewed board appointments suggest continuity in governance, while the absence of disclosed voting results leaves approval margins pending scrutiny.